Stay updated on Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    In the Taiwan locations list, the Taoyuan District entry was removed and replaced with Taoyuan, Taiwan, 333, preserving the same site code. This reflects a standardization of the city name in the study's locations.
    Difference
    0.0%
    Check dated 2026-05-03T19:36:49.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page’s footer revision/version number was updated from v3.5.2 to v3.5.3, reflecting a minor technical update with no change to the displayed study record content.
    Difference
    0.0%
    Check dated 2026-04-26T15:21:57.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T13:35:58.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The study location entry was updated from Padua, Veneto, Italy, 35128 to Padova, Veneto, Italy, 35128.
    Difference
    0.0%
    Check dated 2026-04-05T06:19:24.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added Hepatocellular carcinoma as the condition, included the Genetic and Rare Diseases Information Center as a resource, and updated the location entry from Napoli to Naples, Campania, Italy (80131) with revision to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T16:51:58.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. No study content or usability aspects appear to be affected.
    Difference
    0.0%
    Check dated 2026-03-07T05:26:43.000Z thumbnail image

Stay in the know with updates to Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.